BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16405479)

  • 1. Defining patients with high-risk cutaneous squamous cell carcinoma.
    Veness MJ
    Australas J Dermatol; 2006 Feb; 47(1):28-33. PubMed ID: 16405479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment recommendations in patients diagnosed with high-risk cutaneous squamous cell carcinoma.
    Veness MJ
    Australas Radiol; 2005 Oct; 49(5):365-76. PubMed ID: 16174174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes.
    Veness MJ; Porceddu S; Palme CE; Morgan GJ
    Head Neck; 2007 Jul; 29(7):621-31. PubMed ID: 17230560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mohs micrographic surgery for the management of nonmelanoma skin cancers.
    Cumberland L; Dana A; Liegeois N
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):325-35. PubMed ID: 19698914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic mapping and sentinel lymphonodectomy in recurrent cutaneous squamous cell carcinomas.
    Cecchi R; Buralli L; de Gaudio C
    Eur J Dermatol; 2005; 15(6):478-9. PubMed ID: 16280303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Squamous cell carcinoma].
    Yamazaki N
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1392-7. PubMed ID: 17033226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined sentinel lymphadenectomy and mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma.
    Weisberg NK; Bertagnolli MM; Becker DS
    J Am Acad Dermatol; 2000 Sep; 43(3):483-8. PubMed ID: 10954660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection.
    Sweeny L; Zimmerman T; Carroll WR; Schmalbach CE; Day KE; Rosenthal EL
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):610-7. PubMed ID: 24474713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining, treating, and studying very high-risk cutaneous squamous cell carcinomas.
    Miller SJ
    Arch Dermatol; 2010 Nov; 146(11):1292-5. PubMed ID: 21079069
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of morphologic features and outcome of resected recurrent and nonrecurrent squamous cell carcinoma of the penis: a study of 81 cases.
    Chaux A; Reuter V; Lezcano C; Velazquez EF; Torres J; Cubilla AL
    Am J Surg Pathol; 2009 Sep; 33(9):1299-306. PubMed ID: 19471153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive squamous cell carcinoma of the skin: defining a high-risk group.
    Mullen JT; Feng L; Xing Y; Mansfield PF; Gershenwald JE; Lee JE; Ross MI; Cormier JN
    Ann Surg Oncol; 2006 Jul; 13(7):902-9. PubMed ID: 16788750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons.
    Jambusaria-Pahlajani A; Hess SD; Katz KA; Berg D; Schmults CD
    Arch Dermatol; 2010 Nov; 146(11):1225-31. PubMed ID: 21079057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymphonodectomy in non-melanoma skin cancers.
    Cecchi R; Buralli L; De Gaudioc C
    Chir Ital; 2006; 58(3):347-51. PubMed ID: 16845872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of sentinel lymph node biopsy in the management of thin melanoma.
    Wong SL
    Am J Surg; 2005 Aug; 190(2):196-9. PubMed ID: 16023430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the treatment of non-melanoma skin cancers by surgical excision.
    Pua VS; Huilgol S; Hill D
    Australas J Dermatol; 2009 Aug; 50(3):171-5. PubMed ID: 19659977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant melanoma.
    Califano J; Nance M
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):337-48. PubMed ID: 19698915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature.
    Renzi C; Caggiati A; Mannooranparampil TJ; Passarelli F; Tartaglione G; Pennasilico GM; Cecconi S; Potenza C; Pasquini P
    Eur J Surg Oncol; 2007 Apr; 33(3):364-9. PubMed ID: 17129703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma margins: the importance and need for more evidence-based trials.
    Johnson TM; Sondak VK
    Arch Dermatol; 2004 Sep; 140(9):1148-50. PubMed ID: 15381557
    [No Abstract]   [Full Text] [Related]  

  • 20. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease.
    Veness MJ; Palme CE; Morgan GJ
    Cancer; 2006 Jun; 106(11):2389-96. PubMed ID: 16649220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.